[1]
Blauvelt, A. , Lacour, J.-P., Toth, D., Laquer, V., Beissert, S., Wollenberg, A., Herranz, P., Pink, A., Peris, K. , Fangel, S. and Saeki, H. 2021. Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s59. DOI:https://doi.org/10.25251/skin.5.supp.59.